Zoll Banking On M-Series Superiority Claim In Entering Public AED Market
This article was originally published in The Gray Sheet
Executive Summary
Zoll Medical is expecting the smaller size of its biphasic M-Series automated external defibrillator (AED) combined with FDA-cleared superiority claims over competing devices to result in a sizable chunk of the public access defibrillator market.